<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="letter"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vaccines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vaccines (Basel)</journal-id><journal-id journal-id-type="publisher-id">vaccines</journal-id><journal-title-group><journal-title>Vaccines</journal-title></journal-title-group><issn pub-type="epub">2076-393X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006688</article-id><article-id pub-id-type="pmc">PMC11860959</article-id><article-id pub-id-type="doi">10.3390/vaccines13020141</article-id><article-id pub-id-type="publisher-id">vaccines-13-00141</article-id><article-categories><subj-group subj-group-type="heading"><subject>Comment</subject></subj-group></article-categories><title-group><article-title>Comment on Kerro Dego et al. Evaluation of <italic toggle="yes">Streptococcus uberis</italic> Surface Proteins as Vaccine Antigens to Control <italic toggle="yes">S. uberis</italic> Mastitis in Dairy Cows. <italic toggle="yes">Vaccines</italic> 2021, <italic toggle="yes">9</italic>, 868</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6131-5434</contrib-id><name><surname>Collado</surname><given-names>Rosa</given-names></name><xref rid="c1-vaccines-13-00141" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0563-6414</contrib-id><name><surname>Montbrau</surname><given-names>Carlos</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sabat&#x000e9;</surname><given-names>David</given-names></name></contrib><contrib contrib-type="author"><name><surname>Prenafeta</surname><given-names>Antoni</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Tripp</surname><given-names>Ralph A.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vaccines-13-00141">Hipra Scientific, S.L.U., Avda. La Selva 135, 17170 Amer, Spain; <email>carlos.montbrau@hipra.com</email> (C.M.); <email>antoni.prenafeta@hipra.com</email> (A.P.)</aff><author-notes><corresp id="c1-vaccines-13-00141"><label>*</label>Correspondence: <email>rosa.collado@hipra.com</email>; Tel.: +34-972-43-06-60</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>141</elocation-id><history><date date-type="received"><day>14</day><month>1</month><year>2022</year></date><date date-type="rev-recd"><day>29</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>17</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><related-article related-article-type="commentary-article" ext-link-type="doi" id="ra1-vaccines-13-00141" xlink:href="10.3390/vaccines9080868" vol="9" page="868"/><kwd-group><kwd>mastitis</kwd><kwd>vaccine</kwd><kwd>efficacy</kwd></kwd-group></article-meta></front><body><p>A recent publication by Kerro Dego et al. [<xref rid="B1-vaccines-13-00141" ref-type="bibr">1</xref>] mentioned in its abstract the non-existence of effective vaccines against <italic toggle="yes">Streptococcus uberis</italic> mastitis in dairy cows. We cannot agree with this statement and wish to add a few comments. This statement is at least biased in terms of its definition of efficacy. As is well known, the efficacy of a vaccine is determined by conducting preclinical and clinical trials to determine the reduction in the different parameters associated with an infection [<xref rid="B2-vaccines-13-00141" ref-type="bibr">2</xref>]. The vast majority of commercial veterinary vaccines induce a clear reduction in the different clinical parameters of the disease but are not able to prevent infection in 100% of those vaccinated. This fact does not mean that vaccines are not effective.</p><p>Taking into account the fact that the widespread prophylactic use of antibiotics is no longer sustainable, and considering its importance as a common mastitis control practice, vaccination will be a sustainable procedure to minimize the incidence of clinical and subclinical mastitis [<xref rid="B3-vaccines-13-00141" ref-type="bibr">3</xref>]. Unfortunately, nowadays, we agree that vaccination alone cannot prevent mastitis. But the utilization of vaccines in combination with other infection control measures, such as excellent milking procedures, treatment, segregation, and culling of known infected cattle, could lead to a substantial reduction in the incidence and duration of intramammary infections [<xref rid="B4-vaccines-13-00141" ref-type="bibr">4</xref>], as previously described with the use of Startvac<sup>&#x000ae;</sup> (<italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Escherichia coli</italic> vaccine from Laboratorios Hipra, S.A); or UBAC<sup>&#x000ae;</sup> (<italic toggle="yes">S. uberis</italic> vaccine from Laboratorios Hipra, S.A) [<xref rid="B5-vaccines-13-00141" ref-type="bibr">5</xref>,<xref rid="B6-vaccines-13-00141" ref-type="bibr">6</xref>]. Therefore, describing vaccines as non-effective could lead to misperceptions.</p><p>Additionally, in Europe, any veterinary vaccine registered must comply with the European Pharmacopeia. These guidelines specify the need to perform controlled experimental studies and field-based studies to establish the label claims for a product [<xref rid="B2-vaccines-13-00141" ref-type="bibr">2</xref>]. This means that only those claims that have been demonstrated in preclinical and clinical trials can be included in the product label. Therefore, contrary to what is stated by Kerro Dego et al. [<xref rid="B1-vaccines-13-00141" ref-type="bibr">1</xref>], UBAC<sup>&#x000ae;</sup> has been well characterized in controlled experimental studies and field-based studies to confirm its label claims [<xref rid="B7-vaccines-13-00141" ref-type="bibr">7</xref>]. As described by Collado et al. [<xref rid="B5-vaccines-13-00141" ref-type="bibr">5</xref>], UBAC<sup>&#x000ae;</sup> vaccine has been proven to be efficacious in a controlled experimental study. In this study, results showed that all challenged quarters developed clinical mastitis. Nevertheless, vaccination significantly reduced the clinical signs of mastitis, bacterial count, rectal temperature, and daily milk yield losses after the intramammary infection, and significantly increased the number of quarters with no bacterial isolation and SCC &#x0003c; 200,000 cells/mL at the end of the study. With regard to field-based studies, Puig et al. [<xref rid="B6-vaccines-13-00141" ref-type="bibr">6</xref>] described the efficacy of the UBAC<sup>&#x000ae;</sup> vaccine under field conditions, where 401 vaccinated and 380 control cows in six herds were enrolled. The study showed a significant reduction of 52.5% in the incidence of <italic toggle="yes">S. uberis</italic> clinical mastitis and SCC in animals with <italic toggle="yes">S. uberis</italic> subclinical mastitis (997 vs. 3274 &#x000d7; 10<sup>3</sup> cells/mL). In addition, vaccination with UBAC<sup>&#x000ae;</sup> reduced milk production losses amongst animals with <italic toggle="yes">S. uberis</italic> subclinical mastitis (39.3 vs. 36.6 L/d).</p><p>Finally, with regard to the type of immunological response induced by UBAC<sup>&#x000ae;</sup>, it must be clarified that Collado et al. [<xref rid="B5-vaccines-13-00141" ref-type="bibr">5</xref>] showed clear data on the adaptive (humoral) immune response generated through vaccination with UBAC<sup>&#x000ae;</sup>, contrary to what is stated by Kerro Dego et al. [<xref rid="B1-vaccines-13-00141" ref-type="bibr">1</xref>]. Specifically, data on the immunoglobulin G2 response against lipoteichoic acid (LTA) in sera and milk samples from the vaccinated and control groups were presented in [<xref rid="B5-vaccines-13-00141" ref-type="bibr">5</xref>]. These data demonstrate that cows vaccinated with UBAC<sup>&#x000ae;</sup> developed a specific humoral immune response against <italic toggle="yes">S. uberis</italic> LTA. The presence of these antibodies in milk, as explained by Collado et al. [<xref rid="B5-vaccines-13-00141" ref-type="bibr">5</xref>], could interfere with the binding of the bacteria to the host epithelial cells, as suggested by Czabanska et al. [<xref rid="B8-vaccines-13-00141" ref-type="bibr">8</xref>], when an intramammary infection occurs, preventing the subsequent biofilm formation. This could lead to a reduced <italic toggle="yes">S. uberis</italic> colonization rate of the mammary gland, which has been suggested as the mechanism of protection in other experimental vaccines [<xref rid="B9-vaccines-13-00141" ref-type="bibr">9</xref>,<xref rid="B10-vaccines-13-00141" ref-type="bibr">10</xref>,<xref rid="B11-vaccines-13-00141" ref-type="bibr">11</xref>]. Further studies will be needed in order to prove this hypothesis; however, the fact that UBAC<sup>&#x000ae;</sup> induces a humoral immune response against <italic toggle="yes">S. uberis</italic> LTA is not in doubt.</p></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-vaccines-13-00141"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kerro Dego</surname><given-names>O.</given-names></name>
<name><surname>Almeida</surname><given-names>R.</given-names></name>
<name><surname>Ivey</surname><given-names>S.</given-names></name>
<name><surname>Agga</surname><given-names>G.E.</given-names></name>
</person-group><article-title>Evaluation of <italic toggle="yes">Streptococcus uberis</italic> Surface Proteins as Vaccine Antigens to Control <italic toggle="yes">S. uberis</italic> Mastitis in Dairy Cows</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>868</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9080868</pub-id><pub-id pub-id-type="pmid">34451993</pub-id>
</element-citation></ref><ref id="B2-vaccines-13-00141"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>Council of Europe</collab>
</person-group><article-title>Section 5.2.7. Evaluation of efficacy of veterinary vaccines and immunosera</article-title><source>European Pharmacopoeia 8.0</source><publisher-name>Council of Europe</publisher-name><publisher-loc>Strasbourg, France</publisher-loc><year>2014</year><fpage>591</fpage><lpage>592</lpage></element-citation></ref><ref id="B3-vaccines-13-00141"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rainard</surname><given-names>P.</given-names></name>
<name><surname>Gilbert</surname><given-names>F.B.</given-names></name>
<name><surname>Germon</surname><given-names>P.</given-names></name>
<name><surname>Foucras</surname><given-names>G.</given-names></name>
</person-group><article-title>Invited review: A critical appraisal of mastitis vaccines for dairy cows</article-title><source>J. Dairy. Sci.</source><year>2021</year><volume>104</volume><fpage>10427</fpage><lpage>10448</lpage><pub-id pub-id-type="doi">10.3168/jds.2021-20434</pub-id><pub-id pub-id-type="pmid">34218921</pub-id>
</element-citation></ref><ref id="B4-vaccines-13-00141"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schukken</surname><given-names>Y.H.</given-names></name>
<name><surname>Bronzo</surname><given-names>V.</given-names></name>
<name><surname>Locatelli</surname><given-names>C.</given-names></name>
<name><surname>Pollera</surname><given-names>C.</given-names></name>
<name><surname>Rota</surname><given-names>N.</given-names></name>
<name><surname>Casula</surname><given-names>A.</given-names></name>
<name><surname>Testa</surname><given-names>F.</given-names></name>
<name><surname>Scaccabarozzi</surname><given-names>L.</given-names></name>
<name><surname>March</surname><given-names>R.</given-names></name>
<name><surname>Zalduendo</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Efficacy of vaccination on <italic toggle="yes">Staphylococcus aureus</italic> and coagulase-negative staphylococci intramammary infection dynamics in 2 dairy herds</article-title><source>J. Dairy. Sci.</source><year>2014</year><volume>97</volume><fpage>5250</fpage><lpage>5264</lpage><pub-id pub-id-type="doi">10.3168/jds.2014-8008</pub-id><pub-id pub-id-type="pmid">24881797</pub-id>
</element-citation></ref><ref id="B5-vaccines-13-00141"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Collado</surname><given-names>R.</given-names></name>
<name><surname>Montbrau</surname><given-names>C.</given-names></name>
<name><surname>Sitj&#x000e0;</surname><given-names>M.</given-names></name>
<name><surname>Prenafeta</surname><given-names>A.</given-names></name>
</person-group><article-title>Study of the efficacy of a <italic toggle="yes">Streptococcus uberis</italic> mastitis vaccine against an experimental intramammary infection with a heterologous strain in dairy cows</article-title><source>J. Dairy. Sci.</source><year>2018</year><volume>101</volume><fpage>10290</fpage><lpage>10302</lpage><pub-id pub-id-type="doi">10.3168/jds.2018-14840</pub-id><pub-id pub-id-type="pmid">30219416</pub-id>
</element-citation></ref><ref id="B6-vaccines-13-00141"><label>6.</label><element-citation publication-type="confproc"><person-group person-group-type="author">
<name><surname>Puig</surname><given-names>A.</given-names></name>
<name><surname>Perozo</surname><given-names>E.</given-names></name>
<name><surname>Roura</surname><given-names>F.</given-names></name>
<name><surname>Armengol</surname><given-names>R.</given-names></name>
<name><surname>Pont&#x000e9;</surname><given-names>D.</given-names></name>
<name><surname>Mallo</surname><given-names>J.</given-names></name>
<name><surname>Echevarria</surname><given-names>J.M.</given-names></name>
<name><surname>Arrieta</surname><given-names>C.</given-names></name>
<name><surname>Herrera</surname><given-names>D.</given-names></name>
<name><surname>Franquesa</surname><given-names>O.</given-names></name>
<etal/>
</person-group><article-title>Efficacy and safety under field conditions of the new vaccine UBAC<sup>&#x000ae;</sup> against <italic toggle="yes">Streptococcus uberis</italic> intramammary infection in dairy cows</article-title><source>Proceedings of the 2018 International Bovine Mastitis Conference</source><conf-loc>Milano, Italy</conf-loc><conf-date>11 June 2018</conf-date></element-citation></ref><ref id="B7-vaccines-13-00141"><label>7.</label><element-citation publication-type="webpage"><article-title>European Medicines Agency</article-title><comment>Available online: <ext-link xlink:href="https://www.ema.europa.eu/en/documents/product-information/ubac-epar-product-information_en.pdf" ext-link-type="uri">https://www.ema.europa.eu/en/documents/product-information/ubac-epar-product-information_en.pdf</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-01-29">(accessed on 29 January 2024)</date-in-citation></element-citation></ref><ref id="B8-vaccines-13-00141"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Czaba&#x00144;ska</surname><given-names>A.</given-names></name>
<name><surname>Neiwert</surname><given-names>O.</given-names></name>
<name><surname>Lindner</surname><given-names>B.</given-names></name>
<name><surname>Leigh</surname><given-names>J.A.</given-names></name>
<name><surname>Holst</surname><given-names>O.</given-names></name>
<name><surname>Duda</surname><given-names>K.A.</given-names></name>
</person-group><article-title>Structural analysis of the lipoteichoic acids isolated from bovine mastitis <italic toggle="yes">Streptococcus uberis</italic> 233, <italic toggle="yes">Streptococcus dysgalactiae</italic> 2023 and <italic toggle="yes">Streptococcus agalactiae</italic> 0250</article-title><source>Carbohydr. Res.</source><year>2012</year><volume>361</volume><fpage>200</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2012.09.007</pub-id><pub-id pub-id-type="pmid">23036931</pub-id>
</element-citation></ref><ref id="B9-vaccines-13-00141"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Finch</surname><given-names>J.M.</given-names></name>
<name><surname>Hill</surname><given-names>A.W.</given-names></name>
<name><surname>Field</surname><given-names>T.R.</given-names></name>
<name><surname>Leigh</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Local vaccination with killed <italic toggle="yes">Streptococcus uberis</italic> protects the bovine mammary gland against experimental intramammary challenge with the homologous strain</article-title><source>Infect. Immun.</source><year>1994</year><volume>9</volume><fpage>3599</fpage><lpage>3603</lpage><pub-id pub-id-type="doi">10.1128/iai.62.9.3599-3603.1994</pub-id><pub-id pub-id-type="pmid">8063375</pub-id>
</element-citation></ref><ref id="B10-vaccines-13-00141"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Finch</surname><given-names>J.M.</given-names></name>
<name><surname>Winter</surname><given-names>A.</given-names></name>
<name><surname>Walton</surname><given-names>A.W.</given-names></name>
<name><surname>Leigh</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Further studies on the efficacy of a live vaccine against mastitis caused by <italic toggle="yes">Streptococcus uberis</italic></article-title><source>Vaccine</source><year>1997</year><volume>15</volume><fpage>113</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(96)00307-6</pub-id></element-citation></ref><ref id="B11-vaccines-13-00141"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leigh</surname><given-names>J.A.</given-names></name>
<name><surname>Finch</surname><given-names>J.M.</given-names></name>
<name><surname>Field</surname><given-names>T.R.</given-names></name>
<name><surname>Real</surname><given-names>N.C.</given-names></name>
<name><surname>Winter</surname><given-names>A.</given-names></name>
<name><surname>Walton</surname><given-names>A.W.</given-names></name>
<name><surname>Hodgkinson</surname><given-names>S.M.</given-names></name>
</person-group><article-title>Vaccination with the plasminogen activator from <italic toggle="yes">Streptococcus uberis</italic> induces an inhibitory response and protects against experimental infection in the dairy cow</article-title><source>Vaccine</source><year>1999</year><volume>7&#x02013;8</volume><fpage>851</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(98)00270-9</pub-id><pub-id pub-id-type="pmid">10067691</pub-id>
</element-citation></ref></ref-list></back></article>